beta glucocerebrosidase (Takeda Pharmaceutical)

N/A

Report date: 2025/03/14 16:26:51
NME

Base Information

Drug Namebeta glucocerebrosidase (Takeda Pharmaceutical)
Drug Alias Namebeta-GCase (Takeda Pharmaceutical)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucosylceramidase stimulants
TargetsGlucosylceramidase
Therapy Area/IndicationsGaucher DiseaseParkinson DiseaseLewy Body Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsGaucher DiseaseParkinson DiseaseLewy Body Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A